This is a non-core endpoint: only basic statistics are computed.
Fibrosarcoma
C3_FIBROSARCOMA
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
268 |
4. Check minimum number of eventsNone |
268 |
5. Include endpointsNone |
268 |
6. Filter based on genotype QC (FinnGen only) |
253 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Fibrosarcoma
based on the number of shared cases.
Similar with more cases:
- Fibrosarcoma, including Hilmo
- Solid cancers
- Malignant neoplasm
- Malignant neoplasm
- Solid cancers, including Hilmo
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 253 | 122 | 131 |
| Unadjusted period prevalence (%) | 0.05 | 0.04 | 0.06 |
| Median age at first event (years) | 53.31 | 51.79 | 54.73 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 268
- Matched controls
- 2680
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
130
Kela drug reimbursment
Malignant tumour
+∞
61.9
57
*
8832/3-C44.5
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of trunk
+∞
49.5
46
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
11.3
39.7
45
47
JN4BD
NOMESCO Finland
Extensive body CT
9.1
32.5
43
55
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
31.9
30
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
29.7
28
*
A03FA01
ATC
metoclopramide; systemic, rectal
5.1
29.5
77
196
H02AB02
ATC
dexamethasone; systemic
50.1
29.5
35
8
XX3DW
NOMESCO Finland
Time consuming IT work
9.0
29.3
39
50
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
26.5
25
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
286.7
26.2
26
*
8811/3-C49.2
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
24.3
23
*
C49.25
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip fibrosarcoma
+∞
23.3
22
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
9.0
23.1
30
37
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
22.2
21
*
JN4AD
NOMESCO Finland
Body CT examination
6.4
21.9
39
69
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
9.8
21.5
26
29
Z51.5
ICD-10 Finland
Palliative care
7.7
20.4
30
43
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
20.0
19
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
20.0
19
*
A04AA02
ATC
granisetron; systemic, transdermal
215.2
19.8
20
*
WZC00
NOMESCO Finland
Treatment plan or consultation
3.3
19.1
105
438
JN4CD
NOMESCO Finland
Very extensive body CT
26.0
19.0
26
11
8832/3-C44.7
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of lower limb and hip
+∞
19.0
18
*
ZZR00
NOMESCO Finland
Flap of skin
107.7
18.8
20
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
17.9
17
*
C49.15
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder fibrosarcoma
+∞
17.9
17
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
17.9
17
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
17.9
17
*
C49.10
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder without histology
+∞
17.9
17
*
115
Kela drug reimbursment
Breast cancer
+∞
17.9
17
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.8
17.1
28
45
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
67.9
17.0
19
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
16.8
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
+∞
16.8
16
*
R22.4
ICD-10 Finland
Localized swelling, mass and lump, lower limb
7.9
16.8
24
33
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
96.2
16.8
18
*
8832/3-C44.6
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin of upper limb and shoulder
+∞
15.8
15
*
C49.39
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax other or unspecified tumor
+∞
15.8
15
*
C49.2
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of lower limb, including hip
+∞
15.8
15
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.1
15.7
87
359
ZZR10
NOMESCO Finland
Flap of skin and muscle
169.5
15.6
16
*
QCE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in upper limb
22.6
14.9
21
10
8830/3-C49.2
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
14.7
14
*
C49.21
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip malignant fibrotic histiocytoma
+∞
14.7
14
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
158.3
14.6
15
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
158.3
14.6
15
*
ZZA00
NOMESCO Finland
Split skin graft
11.4
14.6
27
26
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
14.5
14.5
24
18
C49.19
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder other or unspecified tumor
+∞
13.7
13
*
L03AA13
ATC
pegfilgrastim; parenteral
147.1
13.6
14
*
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
11.4
13.6
25
24
ZXE30
NOMESCO Finland
More than five and less than seven hours
6.2
13.5
24
42
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
5.3
12.9
27
55
8832/3-C44.9
ICD-O-3
Dermatofibrosarcoma protuberans, fibrosarcomatous of skin, NOS
+∞
12.6
12
*
159
Kela drug reimbursment
Pazopanib
+∞
12.6
12
*
C49.11
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of upper extremity including shoulder malignant fibrotic histiocytoma
+∞
12.6
12
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
12.6
12
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
12.6
12
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.8
12.5
30
69
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.8
12.5
30
69
D48.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Connective and other soft tissue
9.6
12.0
24
27
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
68.0
11.7
13
*
WF002
NOMESCO Finland
Radical radiotherapy
68.0
11.7
13
*
A04AA01
ATC
ondansetron; systemic, rectal
9.0
11.6
24
29
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
11.5
11
*
343
Kela drug reimbursment
Pazopanib
+∞
11.5
11
*
C49.99
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue other or unspecified tumor
+∞
11.5
11
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
11.5
11
*
ZZQ10
NOMESCO Finland
Free microvascular graft of skin and muscle
+∞
11.5
11
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
11.5
11
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
125.2
11.5
12
*
D17.1
ICD-10 Finland
Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk
5.9
10.9
20
36
QDE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in lower limb
13.7
10.8
18
14
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
10.7
10.7
20
20
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.4
10.7
150
940
C49.30
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thorax without histology
+∞
10.5
10
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
10.5
10
*
8830/3-C49.6
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of trunk, NOS
+∞
10.5
10
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
8830/3-C49.1
ICD-O-3
Malignant fibrous histiocytoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
WF001
NOMESCO Finland
Preoperative radiotherapy
+∞
10.5
10
*
8810/3-C49.1
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
10.5
10
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
10.5
10
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
10.5
10
*
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
10.5
10
*
L02BG04
ATC
letrozole; oral
41.7
10.0
12
*
HA1AA
NOMESCO Finland
X-ray mammography
8.3
9.8
21
27
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
8.3
9.8
21
27
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
4.1
9.5
27
71
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
103.5
9.5
10
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
9.4
9
*
C49.35
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the thoracic fibrosarcoma
+∞
9.4
9
*
C49.00
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the head, face and neck without histology
+∞
9.4
9
*
116
Kela drug reimbursment
Prostate cancer
+∞
9.4
9
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
8811/3-C49.1
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of upper limb and shoulder
+∞
9.4
9
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
9.4
9
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
9.4
9
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
9.4
9
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.9
8.6
46
181
YX9VG
NOMESCO Finland
Other MRI eamination with high intensity magnet for dose design of radiotherapy
+∞
8.4
8
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
8.4
8
*
PJD52
NOMESCO Finland
Block dissection of axillary lymph nodes
+∞
8.4
8
*
A04AD12
ATC
aprepitant; systemic
+∞
8.4
8
*
L03AA02
ATC
filgrastim; parenteral
+∞
8.4
8
*
8810/3-C49.2
ICD-O-3
Fibrosarcoma, NOS, of connective, Subcutaneous and other soft tissues of lower limb and hip
+∞
8.4
8
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
8.4
8
*
L02BA01
ATC
tamoxifen; oral
+∞
8.4
8
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
8.4
8
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
22.8
8.1
11
5
Z31.5
ICD-10 Finland
Genetic counselling
6.5
8.0
20
33
WX402
NOMESCO Finland
General anaesthesia
2.5
7.9
58
268
HAB40
NOMESCO Finland
Wedge excision of mammary gland
46.4
7.8
9
*
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
46.4
7.8
9
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
7.7
55
251
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
19.0
7.7
11
6
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
12.3
7.7
13
11
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
3.2
7.6
32
110
R4120
NOMESCO Finland
Occupational therapy
3.5
7.5
26
79
ZZF00
NOMESCO Finland
Graft of adipose tissue
82.3
7.5
8
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
7.2
7.4
17
25
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
C49.49
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the abdomen other or unspecified tumor
+∞
7.3
7
*
Z42.4
ICD-10 Finland
Follow-up care involving plastic surgery of lower extremity
+∞
7.3
7
*
C49.28
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip Ewing's sarcoma
+∞
7.3
7
*
NAR40
NOMESCO Finland
Block excision of soft tissue tumour of spine, unspecified
+∞
7.3
7
*
Z42.2
ICD-10 Finland
Follow-up care involving plastic surgery of other parts of trunk
+∞
7.3
7
*
C49.1
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of upper limb, including shoulder
+∞
7.3
7
*
L01AX03
ATC
temozolomide; systemic
+∞
7.3
7
*
8811/3-C49.5
ICD-O-3
Myxofibrosarcoma of connective, Subcutaneous and other soft tissues of pelvis
+∞
7.3
7
*
HA6AA
NOMESCO Finland
Extra corporeal mammography of operated mammary gland
+∞
7.3
7
*
C49.55
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of pelvic fibrosarcoma
+∞
7.3
7
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
7.3
7
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
7.3
7
*
YN1BD
NOMESCO Finland
Extensive CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
6.9
7.2
17
26
NK6AN
NOMESCO Finland
Total body bone isotope imaging
30.9
7.2
9
*
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
12.5
7.1
12
10
B01AB05
ATC
enoxaparin; parenteral
2.1
7.1
89
513
S18
ICPC
Laceration/cut
2.0
7.0
133
888
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.8
7.0
37
145
WX302
NOMESCO Finland
Thoracal epidural anesthesy
7.0
6.9
16
24
WZC30
NOMESCO Finland
Teaching
2.6
6.9
43
183
N02AA01
ATC
morphine; systemic, rectal
17.2
6.8
10
6
GA1CG
NOMESCO Finland
Extensive MRI of chest
41.1
6.8
8
*
JN6AD
NOMESCO Finland
CT of torso and neck
23.2
6.7
9
*
N02AA05
ATC
oxycodone; systemic
2.4
6.7
51
239
QAA05
NOMESCO Finland
Incision for biopsy of skin of head or neck
12.7
6.6
11
9
NAR20
NOMESCO Finland
Complete excision of soft tissue tumour of spine, unspecified
71.5
6.5
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
71.5
6.5
7
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
8.5
6.4
13
16
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.7
6.3
20
57
NCR30
NOMESCO Finland
Extended excision of soft tissue tumour of elbow or forearm
+∞
6.3
6
*
L01EX03
ATC
pazopanib; oral
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
17131
ICD-8 Finland
Malignant neoplasm of connective and other soft tissue, Lower limb (including hip)
+∞
6.3
6
*
C49.59
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the pelvis other or unspecified tumor
+∞
6.3
6
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
6.3
6
*
C49.90
ICD-10 Finland
Malignant tumor in unspecified localization in connective tissue and soft tissue without histology
+∞
6.3
6
*
C49.3
ICD-10 Finland
Malignant neoplasm: Connective and soft tissue of thorax
+∞
6.3
6
*
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
+∞
6.3
6
*
C49.45
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of abdominal fibrosarcoma
+∞
6.3
6
*
HA1CG
NOMESCO Finland
Extensive MRI examination of mammary gland with high intensity magnet
+∞
6.3
6
*
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
35
115
3.35
8.93
4.9
1.5
4.19
2.55
ug/l
0.40
29
86
157
1139
1.91
6.23
11.3
6.0
4.04
4.33
e9/l
0.87
137
979
135
946
1.86
5.83
3.0
2.4
—
—
estimate
—
0
0
149
1121
1.74
4.72
9.0
3.8
12.91
12.23
umol/l
0.18
143
1054
81
512
1.83
4.67
2.5
2.0
—
—
—
0
0
12
22
5.66
4.66
1.2
1.2
—
—
—
0
0
56
324
1.92
4.21
3.5
3.3
0.82
0.83
mmol/l
0.11
51
304
132
988
1.66
4.05
6.8
6.2
1.21
1.21
mmol/l
0.11
125
904
129
969
1.64
3.84
5.7
3.9
34.98
35.71
g/l
0.81
124
897
30
144
2.22
3.70
4.8
10.4
24.71
25.01
mmol/l
0.20
30
144
48
276
1.90
3.66
5.5
6.9
0.64
1.27
mmol/l
0.63
40
236
195
1644
1.68
3.52
10.1
5.6
81.37
78.73
u/l
0.39
189
1518
140
1115
1.54
3.00
7.2
6.7
1.21
1.21
mmol/l
0.10
122
981
9
23
4.01
2.80
1.0
1.0
—
—
—
0
0
31
169
1.94
2.77
2.5
2.1
0.21
0.20
g/l
0.16
31
152
49
321
1.64
2.39
4.3
6.4
105.47
103.92
mmol/l
1.88
49
321
8
22
3.71
2.38
1.4
1.5
27.57
170.41
u/ml
—
8
22
56
398
1.51
1.94
2.0
1.8
—
—
—
0
0
43
292
1.56
1.82
2.0
1.8
—
—
—
0
0
25
147
1.77
1.81
1.7
1.6
—
—
—
0
0
156
1347
1.38
1.81
4.6
4.6
6.60
6.78
mmol/l
0.70
151
1277
13
60
2.23
1.81
1.5
1.4
—
—
—
0
0
8
30
2.72
1.74
1.5
1.6
—
—
—
0
0
5
13
3.90
1.72
1.2
1.1
—
—
—
0
0
10
40
2.56
1.68
1.5
1.3
—
—
—
0
0
78
609
1.40
1.65
3.1
3.1
0.44
0.48
e6/l
0.09
60
437
44
311
1.50
1.57
2.1
1.8
—
—
—
0
0
28
416
0.63
1.47
1.3
1.3
21.30
37.32
iu/ml
—
5
128
32
214
1.56
1.46
3.7
3.2
—
—
—
0
0
6
22
2.77
1.44
1.5
1.4
—
—
—
0
0
52
392
1.41
1.34
3.0
2.8
1.04
1.18
e6/l
0.12
29
205
23
151
1.57
1.16
6.9
9.2
0.67
0.68
%
0.01
23
151
34
244
1.45
1.15
2.5
2.3
10.65
8.10
umol/l
0.22
26
221
7
30
2.37
1.13
1.3
1.3
—
—
—
0
0
10
51
2.00
1.12
1.4
1.3
—
—
—
0
0
10
51
2.00
1.12
1.4
1.3
—
—
—
0
0
72
597
1.28
0.99
3.4
3.5
0.13
0.00
estimate
0.48
24
159
41
517
0.76
0.88
1.5
1.7
481.63
27209747.22
pmol/l
0.50
32
430
11
64
1.75
0.87
7.6
4.7
1.13
1.62
mg/l
1.70
11
56
176
1631
1.23
0.85
4.1
4.4
12.61
12.22
mm/h
0.14
162
1519
154
1409
1.22
0.84
3.4
3.2
42.90
48.19
u/l
0.55
144
1321
222
2115
1.29
0.82
19.8
14.9
25.86
25.35
mg/l
0.08
184
1713
10
163
0.60
0.81
2.2
2.7
—
20.88
—
0
12
11
66
1.70
0.80
1.4
1.2
—
—
—
0
0
11
66
1.70
0.80
2.8
3.6
—
—
—
0
0
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
45
362
1.29
0.79
3.1
3.1
1.41
2.27
e6/l
0.38
21
173
128
1157
1.20
0.78
3.8
4.1
0.00
0.00
estimate
-0.00
29
209
9
53
1.72
0.76
1.1
1.3
—
—
—
0
0
24
176
1.40
0.76
3.5
2.4
68.73
63.78
ml/min/173m2
0.18
11
67
5
24
2.10
0.75
1.2
1.4
—
—
—
0
0
98
867
1.21
0.74
3.8
4.1
0.04
0.01
estimate
0.30
23
157
5
25
2.02
0.73
1.2
1.5
—
—
—
0
0
131
1193
1.19
0.72
2.7
2.8
—
—
—
0
0
10
156
0.63
0.69
4.5
1.7
—
—
—
0
0
125
1137
1.19
0.69
3.8
4.1
0.00
0.00
estimate
-0.00
28
199
5
27
1.87
0.69
1.4
1.3
—
—
—
0
0
35
434
0.78
0.68
1.9
1.7
1050.22
1233.79
nmol/l
0.55
27
344
182
1712
1.20
0.67
24.6
18.1
13.82
13.64
%
1.00
182
1693
36
290
1.28
0.64
5.9
5.2
32.86
32.41
%
0.09
21
183
8
50
1.62
0.62
1.3
1.4
—
—
—
0
0
127
1166
1.17
0.61
3.8
4.1
0.00
0.04
estimate
0.79
26
197
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
23
0.00
0.58
0.0
1.2
—
—
—
0
0
10
65
1.56
0.56
1.1
1.2
—
—
—
0
0
10
65
1.56
0.56
1.1
1.2
—
—
—
0
0
6
37
1.64
0.56
1.2
1.4
—
—
—
0
0
205
2130
0.84
0.55
5.2
5.4
4.60
4.53
mmol/l
0.42
187
1977
22
170
1.32
0.53
1.3
1.5
—
—
—
0
0
79
707
1.17
0.51
2.4
2.3
54.23
64.51
u/l
0.72
70
655
19
145
1.33
0.50
1.5
1.6
—
—
—
0
0
204
2115
0.85
0.49
5.3
5.3
5.94
6.06
mmol/l
0.96
185
1932
199
2067
0.86
0.49
7.1
7.0
39.30
40.04
mmol/mol
0.84
183
1932
7
45
1.57
0.49
1.0
1.9
0.70
0.86
nmol/l
—
7
37
87
954
0.87
0.47
3.0
4.0
23.96
98.42
ng/l
0.72
66
709
7
49
1.44
0.46
1.1
1.5
—
—
—
0
0
7
49
1.44
0.46
1.7
2.2
101.57
92.96
%
—
7
49
7
49
1.44
0.46
1.0
1.3
—
—
—
0
0
210
2169
0.85
0.46
5.7
6.2
2.72
2.62
mmol/l
0.87
191
2005
204
2111
0.86
0.45
5.1
5.3
1.42
1.47
mmol/l
0.93
186
1942
49
559
0.85
0.44
3.8
4.3
1.02
1.02
kg/l
0.15
32
352
88
804
1.14
0.43
2.5
3.3
1234.91
1545.02
ng/l
0.34
82
689
5
33
1.52
0.41
1.6
1.5
202.80
276.59
pmol/l
—
5
28
17
132
1.31
0.41
1.8
1.7
—
—
—
0
0
42
481
0.85
0.40
1.3
1.3
0.48
1.50
u/ml
—
6
142
0
18
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
45
509
0.86
0.37
3.4
4.2
32.10
512.60
ng/l
2.76
36
415
5
37
1.36
0.37
1.4
1.2
—
—
—
0
0
10
135
0.73
0.37
4.3
1.7
—
—
—
0
0
9
70
1.30
0.37
6.4
1.2
36.93
46.12
mg/l
—
9
61
9
70
1.30
0.37
6.4
1.2
30.44
33.44
mg/l
—
9
60
12
90
1.35
0.36
1.1
1.3
—
—
—
0
0
6
41
1.47
0.36
1.3
1.7
—
—
—
0
0
6
44
1.37
0.34
1.3
1.3
—
—
—
0
0
6
44
1.37
0.34
1.7
1.6
974.78
1178.86
mu/l
—
6
36
15
120
1.26
0.31
3.8
3.3
4.85
4.54
pmol/l
0.50
15
107
91
852
1.10
0.29
3.8
4.0
5.55
28.52
mg/mmol
0.57
60
542
15
121
1.25
0.29
1.1
1.3
67.37
117.06
u/ml
—
6
45
35
309
1.15
0.28
1.2
1.4
—
—
—
0
0
53
482
1.12
0.28
1.8
1.6
0.90
1.14
mg/l
0.65
42
370
32
282
1.15
0.27
8.3
6.9
—
—
—
0
0
23
199
1.17
0.24
3.5
4.2
80.13
85.50
ng/l
0.14
23
176
228
2240
1.12
0.23
14.6
10.3
27.35
25.35
u/l
0.86
220
2162
5
38
1.32
0.23
1.4
1.2
—
—
—
0
0
5
39
1.29
0.23
3.4
3.2
12.04
10.38
pmol/l
—
5
39
209
2046
1.10
0.22
21.2
14.1
80.17
76.93
ml/min/173m2
1.52
197
1892
67
627
1.09
0.22
4.9
4.1
0.00
0.00
estimate
-0.00
27
189
0
11
0.00
0.21
0.0
1.1
—
1.03
—
0
6
0
11
0.00
0.21
0.0
1.4
—
9.15
—
0
11
0
10
0.00
0.21
0.0
1.3
—
—
—
0
0
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
53
1.14
0.19
1.0
1.2
—
17.13
—
0
6
7
59
1.19
0.18
1.1
1.2
—
—
—
0
0
34
371
0.90
0.18
1.3
1.3
1.14
8.48
u/ml
1.99
14
148
172
1680
1.07
0.17
3.7
4.1
15.04
14.96
pmol/l
0.17
156
1534
85
814
1.06
0.16
5.2
4.2
2.36
2.01
ug/l
0.36
74
719
18
202
0.88
0.15
1.3
2.5
0.47
0.36
e6/l
0.29
18
185
202
1989
1.06
0.13
4.8
5.3
1.86
1.97
mu/l
0.75
184
1824
24
220
1.10
0.12
1.1
1.4
—
—
—
0
0
49
465
1.07
0.12
2.9
2.8
0.65
0.77
ug/l
0.65
33
299
199
2017
0.95
0.11
4.2
4.5
1.38
1.28
mmol/l
0.96
182
1844
76
734
1.05
0.10
1.5
1.7
24.57
20.38
nmol/l
1.16
65
622
13
116
1.13
0.09
2.6
3.6
1.02
1.02
ratio
0.82
13
109
5
61
0.82
0.08
1.4
1.4
0.00
0.00
g/l
—
5
53
5
61
0.82
0.08
1.0
1.2
—
—
—
0
0
5
63
0.79
0.08
1.4
1.4
0.00
0.00
g/l
—
5
57
7
67
1.05
0.08
1.0
1.4
—
—
—
0
0
59
610
0.96
0.08
2.2
2.3
2.82
2.80
mg/l
0.02
52
521
7
82
0.85
0.07
1.3
1.5
—
—
—
0
0
9
87
1.04
0.07
1.3
1.5
—
—
—
0
0
93
910
1.03
0.07
1.9
2.0
1.33
1.32
mmol/l
0.08
76
758
112
1101
1.03
0.06
2.0
2.2
102.06
95.39
pmol/l
0.61
69
548
20
212
0.94
0.05
2.4
1.8
321.25
400.17
nmol/l
0.95
20
198
11
100
1.10
0.05
1.0
1.0
—
—
—
0
0
58
594
0.97
0.04
2.7
2.4
345.43
352.75
umol/l
0.21
53
518
102
1012
1.01
0.01
2.9
2.9
179.15
119.35
ug/l
1.16
96
932
101
1004
1.01
0.00
2.4
2.5
76.20
80.23
nmol/l
0.77
94
892
15
147
1.02
0.00
1.1
1.2
293.80
206.61
u/ml
0.24
15
134
65
655
0.99
0.00
3.5
3.9
21.94
24.38
%
0.68
35
302
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
58
0.86
-0.00
1.0
1.3
—
1.12
—
0
5
0
7
0.00
-0.00
0.0
2.7
—
10.37
—
0
7
0
8
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
6
67
0.89
-0.00
1.3
1.2
—
—
—
0
0
6
62
0.97
-0.00
2.0
1.7
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
23.54
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
11.38
—
0
8
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
6.24
—
0
5
0
7
0.00
-0.00
0.0
5.6
—
5.94
—
0
7
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
6
61
0.98
-0.00
1.3
1.6
—
0.08
—
0
13
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
2.7
—
4.68
—
0
7
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
6.0
—
11.12
—
0
6
0
9
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_FIBROSARCOMA – Fibrosarcoma
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).